Bioneeds

What Bioneeds does

Bioneeds India Private Limited is a Bangalore-based preclinical contract research organization founded in 2006/2007 (CIN shows 2007) that provides integrated discovery, development, and regulatory services to pharmaceutical, biopharmaceutical, agrochemical, industrial chemical, herbal/nutraceutical, cosmetics, and animal-health companies. The company operates two facilities: a 250,000 sq ft GLP-accredited Preclinical Development Centre on a 5-acre campus in Nelamangala with an 85-room vivarium, inhalation toxicology units, in vitro labs, and bioanalytical infrastructure, plus a 50,000 sq ft Chemistry Facility in Peenya Industrial Area focused on medicinal chemistry, custom synthesis, chiral chemistry, process R&D, and CGMP manufacturing. Service lines span IND/NDA-enabling toxicology, DMPK, bioanalytical and biosimilarity testing, agrochemical registration studies, EU REACH compliance testing, and clinical research delivered through an integrated model under the Veeda Lifesciences umbrella alongside parent Veeda Clinical Research.

The company's core technology stack is its regulatory-accredited wet-lab infrastructure rather than software or AI: it is certified under OECD GLP (NGCMA), ISO 17025 / NABL, AAALAC International, OLAW (NIH), CCSEA, CIBRC, RCGM, and holds a Government Drug Testing License, with stated conformance to USFDA, EPA, OECD, EEC, EMEA, MHRA, ANVISA, DCGI, and CIBRC norms. Across 15+ years the company reports 23,500+ GLP studies submitted to global regulators.

The business model is professional-services fee-for-service B2B contract research: study pricing is quote-based and project-scoped, distribution is direct enterprise sales with website/email/phone inbound, and customer segments are split across pharma, biopharma, agrochem, REACH testing, herbal/nutraceutical, and cosmetics/animal health. Bioneeds is privately held and operates as a material subsidiary of Veeda Clinical Research, which is backed by private equity firm CX Partners and refiled a Draft Red Herring Prospectus with SEBI in February 2025 for an IPO. Dr. S. N. Vinaya Babu (Founder & Managing Director) and Ms. Sapna Y R (Chief Business Officer) lead a CTO-structured technical leadership team.

Name

Bioneeds

Legal name

Bioneeds India Private Limited

Website

https://bioneeds.in

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Bioneeds is a Bangalore-based preclinical contract research organization providing integrated discovery, development, and regulatory services — including GLP toxicology, DMPK, bioanalysis, agrochemical and REACH testing — to pharmaceutical, biopharmaceutical, agrochemical, and industrial chemical sponsors globally.

Ownership category

akta.pro rank

Product category

Preclinical Contract Research Organization (CRO) Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

akta.pro secondary industries

Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Preclinical contract research
• Drug development services
• GLP toxicology testing
• Agrochemical regulatory testing
• Biopharmaceutical analytical services

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Preclinical Contract Research Services: Bioneeds provides fee-for-service preclinical research services including toxicology studies (general, inhalation, genetic, immunotoxicity), DMPK studies, pharmacology, bioanalytical services, and regulatory submissions for pharmaceutical, biopharmaceutical, agrochemical, and industrial chemical companies. Revenue is generated through project-based contracts for regulatory-driven drug development studies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Bioneeds India Private Limited is a preclinical Contract Research Organization (CRO) providing integrated discovery, development, and regulatory services to pharmaceutical, biopharmaceutical, agrochemical, and industrial chemical companies. Services span IND/NDA-enabling toxicology studies, DMPK, inhalation toxicology, genetic toxicology, pharmacology, bioanalytical testing, medicinal/custom chemistry synthesis, and REACH compliance testing, delivered from GLP-certified, AAALAC-accredited, and ISO 17025-accredited Bangalore facilities. The company operates as a material subsidiary of Veeda Clinical Research, enabling end-to-end delivery from preclinical through clinical research under a single integrated CRO model.

Product overview

Bioneeds India Private Limited is a preclinical Contract Research Organization (CRO) providing integrated discovery, development, and regulatory services. The company operates as a unified platform offering six interconnected service lines: Pharmaceutical Services (IND/NDA-enabling studies, DMPK, toxicology, formulation), Biopharmaceutical Services (biosimilars, biologics characterization), Agrochemical Services (regulatory testing), REACH Testing Services (chemical compliance), Chemistry Services (medicinal/custom synthesis), and Clinical Research Services (end-to-end clinical trials). These services are delivered through GLP-certified facilities and integrate across the drug development continuum from early discovery through clinical phases.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Services Integrated preclinical support for pharmaceutical development programs covering IND & NDA-enabling studies, impurity qualification, 505(b)(2) development, DMPK, genetic and mammalian toxicology, formulation development, and bioanalytical services for pharmaceutical innovator and generic companies.
• Biopharmaceutical Services Characterization and bioanalytical testing services in support of preclinical and clinical development of biologics, biosimilars, peptides, protein drugs, vaccines, and other novel biologics drug products, including bioanalytical assay development, immunogenicity analysis, PK/PD profiling, biomarker analysis, and biosimilarity testing.
• Agrochemical Services Comprehensive regulatory testing services for agrochemicals covering Active Ingredients, Final Products, Technical Grade (Herbicides, Fungicides, Insecticides), and biocides, including acute toxicity, physico-chemical testing, sub-chronic and chronic studies, genotoxicity, and ecotoxicity studies compliant with CIBRC, OECD, EC, and EPA guidelines.
• REACH Testing Services REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) testing services for industrial chemicals, plant protection products, and biocides, including analytical methods, toxicological studies, ecotoxicology studies, and endocrine disruptor studies for EU market access.
• Chemistry Services State-of-the-art chemistry laboratory services including medicinal chemistry, agrochemical research, chiral synthesis and resolution, custom synthesis, process R&D, CGMP manufacturing, and analytical services from method development to impurity profiling, delivered from a 50,000 sq ft Peenya facility.
• Clinical Research Services End-to-end clinical research services delivered through an integrated CRO model spanning Discovery, Preclinical, and Clinical development, including bioavailability/bioequivalence studies, Phase I-IV trials, bioanalytical services, data management, regulatory services, and pharmacovigilance for global biopharmaceutical clients.

Quantifiable outcome

• 23,500+ GLP Studies submitted to regulatory bodies across the Globe
• +1 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Two partnerships are on record, tiered core.

• Veeda LifesciencescoreStrategic or Co-development PartnerBioneeds is integrated with Veeda Lifesciences umbrella to deliver comprehensive preclinical and clinical research solutions. This integration enables unified capabilities spanning discovery, preclinical, and clinical development under a single organization.
• Veeda Clinical ResearchcoreStrategic or Co-development PartnerVeeda Clinical Research is the principal stakeholder of Bioneeds. Clinical Research Services at Bioneeds are delivered through an integrated CRO model in collaboration with Veeda, which contributes extensive expertise and global experience in delivering high-quality clinical research solutions. Veeda provides full-service and functional clinical solutions supporting critical drug development programs for global biopharmaceutical companies.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Syngene International: India-based integrated CRO offering preclinical toxicology, DMPK, and discovery services for pharma and biopharma clients. Directly comparable to Bioneeds in regulatory-grade preclinical capability and India cost structure, with a larger scale.
• Sai Life Sciences: Hyderabad-headquartered CRO providing discovery, CMC and preclinical services to global pharma. Competes head-on with Bioneeds in the India-based preclinical and chemistry services segment for innovator and generic sponsors.
• Aragen Life Sciences (formerly GVK Biosciences): India-based CRO with discovery, preclinical and process R&D offerings. Closely comparable service mix and client base to Bioneeds in integrated preclinical drug development for pharma and agrochemical clients.
• Anthem Biosciences: Bangalore-headquartered CRO/CDMO with discovery, process chemistry, and preclinical services. Overlaps with Bioneeds' chemistry and preclinical capabilities for similar Indian and global pharma customers.
• Jubilant Biosys: India-based contract research business (part of Jubilant Pharmova) offering discovery and preclinical services. Comparable to Bioneeds in integrated discovery-to-preclinical delivery to global biopharma sponsors.

Broad incumbents

• Charles River Laboratories: Global leader in preclinical CRO services including toxicology, safety assessment and research models. Competes with Bioneeds for outsourced GLP toxicology work, especially for global pharma sponsors.
• WuXi AppTec / WuXi Biology: Large global CRO/CDMO offering preclinical, bioanalytical and discovery services. Competes with Bioneeds for nonclinical toxicology, DMPK and bioanalytical studies from sponsors seeking Asia-based capacity.
• Eurofins Scientific: Global testing services group with significant presence in pharma/agrochemical/REACH testing. Comparable to Bioneeds on REACH, agrochemical registration studies, and central/bioanalytical laboratory services.
• Labcorp Drug Development (formerly Covance): Global CRO with deep preclinical and central laboratory capability. Comparable to Bioneeds on GLP toxicology, bioanalytical, and central lab services for global sponsor pipelines.

Others

• Veeda Clinical Research: Parent/principal stakeholder of Bioneeds, providing clinical pharmacology, BA/BE, and Phase I-IV CRO services. Directly comparable technology and operational overlap, but operates as the clinical-stage sister entity rather than a competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/bioneeds?lang=en
• Facebookfacebook.com/bioneeds.in
• LinkedInlinkedin.com/company/bioneeds-india-private-limited

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioneeds